Esperion Therapeutics
ESPR
#7075
Rank
NZ$0.55 B
Marketcap
$2.83
Share price
0.57%
Change (1 day)
36.52%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$1.12 B

According to Esperion Therapeutics's latest financial reports the company's total liabilities are NZ$1.12 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$1.04 B16.04%
2022-12-31NZ$0.90 B6.6%
2021-12-31NZ$0.84 B35.2%
2020-12-31NZ$0.62 B116.71%
2019-12-31NZ$0.28 B200.77%
2018-12-31NZ$95.86 M105.42%
2017-12-31NZ$46.66 M94.61%
2016-12-31NZ$23.98 M97.21%
2015-12-31NZ$12.15 M-1.88%
2014-12-31NZ$12.39 M142.17%
2013-12-31NZ$5.11 M-83.02%
2012-12-31NZ$30.13 M185.5%
2011-12-31NZ$10.55 M
2002-12-31NZ$24.19 M-15.15%
2001-12-31NZ$28.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$1.91 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.87 B 155.67%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$207.24 B 18,307.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.73 B 1,031.45%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.99 B-11.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.21 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA